Half of Canadian families have a member who struggles with a mental health problem, yet the available treatments remain limited and inadequate. The result is poor outcomes for patients and heavy costs for our health care system. As Canada Research Chair in Therapeutics for Mental Health, Dr. Gabriella Gobbi is using a bench-to-bedside method to study drugs to treat mental illness, with the goal of offering a more personalized approach to medicine.
The major focus of the lab is investigating the psychedelics for mental health treatments, selective melatonin compounds for the treatment of pain and insomnia and cannabinoids for pain and anxiety.
The Team
Meet the hardworking graduate and post-graduate individuals working on current discoveries
